Mataro
Barcelona
Minoryx
is a Spain-based biotechnology company that develops and commercializes novel therapeutics for the treatment of orphan central nervous system disorders... Read moreMinoryx
is a Spain-based biotechnology company that develops and commercializes novel therapeutics for the treatment of orphan central nervous system disorders... Read moreNews
Mar 12, 2025
PharmaTimes
Minoryx: Minoryx doses first patient with leriglitazone in Rett syndrome study
Dec 12, 2024
PharmaTimes
Minoryx: Leriglitazone meets primary endpoint in pivotal cALD trial
Nov 17, 2022
Global Legal Chronicle
Minoryx: Minoryx Therapeutics and Neuraxpharm Group's Development of a New CNS Therapy in Europe
Jun 03, 2022
Born2Invest
Minoryx: Minoryx Therapeutics Raises 51M to Complete Commercialization of its CNS drug
Jun 01, 2022
Global University Venturing
Minoryx: Deals: June 1, 2022 - Global University Venturing
May 31, 2022
BioCentury
Minoryx: Minoryx prepares for rare disease submission with 51M financing
Feb 17, 2021
Born2Invest
Minoryx: Significant Phase 3 results for the Belgian-Spanish biotech company Minoryx
Dec 17, 2020
Pharmabiz
Minoryx: Minoryx Therapeutics announces positive results from phase 2 FRAMES trial of leriglitazone to treat Friedreich's ataxia
Oct 30, 2020
MarketScreener
Minoryx: Espagne : la BEI accorde Minoryx un financement hauteur de 25 millions d'EUR en appui au dveloppement de thrapies rvolutionnaires pour le traitement de maladies neurodgnratives orphelines
Sep 24, 2020
Biospectrum Asia
Minoryx: Minoryx inks $78M worth deal with Sperogenix to focus on rare diseases, Read more
Minoryx Competitors
1
2
3
4
5
6
7
8
9
10